Cargando…

Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer

BRD4, a Bromodomain and Extraterminal (BET) protein family member, is a promising anti-cancer drug target. However, resistance to BET inhibitors targeting BRD4 is common in solid tumors. Here, we show that cancer-associated fibroblast (CAF)-activated stromal signaling, interleukin-6/8-JAK2, induces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenyu, Tang, Yen-An, Xiao, Qian, Lee, Wee Chyan, Cheng, Bing, Niu, Zhitong, Oguz, Gokce, Feng, Min, Lee, Puay Leng, Li, Baojie, Yang, Zi-huan, Chen, Yu-feng, Lan, Ping, Wu, Xiao-Jian, Yu, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295257/ https://www.ncbi.nlm.nih.gov/pubmed/34290255 http://dx.doi.org/10.1038/s41467-021-24687-4

Ejemplares similares

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4
por: Calder, Jack, et al.
Publicado: (2021)

Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
por: Malvezzi, Francesca, et al.
Publicado: (2021)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy
por: Ma, Shijun, et al.
Publicado: (2022)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer
por: Ong, Li-Teng, et al.
Publicado: (2022)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

BRD9-mediated chromatin remodeling suppresses osteoclastogenesis through negative feedback mechanism
por: Du, Jiahui, et al.
Publicado: (2023)

RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling
por: Brasier, Allan R.
Publicado: (2020)

EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
por: Bao, Yi, et al.
Publicado: (2020)

KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer
por: Wang, Wenyu, et al.
Publicado: (2018)

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022)

BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
por: Korb, Erica, et al.
Publicado: (2015)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
por: Zengerle, Michael, et al.
Publicado: (2015)

FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma
por: Lindén, Malin, et al.
Publicado: (2022)

The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
por: Benito, E, et al.
Publicado: (2017)

Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2016)

Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence
por: DiBenedetto, Angela J, et al.
Publicado: (2008)

Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
por: Bolden, Jessica E., et al.
Publicado: (2014)

The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression
por: Wu, Tao, et al.
Publicado: (2015)

A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells
por: Gatchalian, Jovylyn, et al.
Publicado: (2018)

Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
por: Dai, Xiangpeng, et al.
Publicado: (2017)

Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling
por: Zhong, Beiping, et al.
Publicado: (2021)

Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation
por: Ai, Nanping, et al.
Publicado: (2011)

BET in Pulmonary Arterial Hypertension: Exploration of BET Inhibitors to Reverse Vascular Remodeling
por: Dai, Zhiyu, et al.
Publicado: (2019)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023)

BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion
por: Blee, Alexandra M., et al.
Publicado: (2016)

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer
por: Hajmirza, Azadeh, et al.
Publicado: (2018)

Retinoblastoma protein as an intrinsic BRD4 inhibitor modulates small molecule BET inhibitor sensitivity in cancer
por: Ding, Donglin, et al.
Publicado: (2022)

Epstein-Barr Virus Synergizes with BRD7 to Conquer c-Myc-Mediated Viral Latency Maintenance via Chromatin Remodeling
por: Li, Shen, et al.
Publicado: (2023)

Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression
por: Dai, Jin, et al.
Publicado: (2019)

Editorial: BET proteins in chromatin architecture, transcription and disease
por: Singh, Amit Kumar, et al.
Publicado: (2022)

I-BET151 suppresses osteoclast formation and inflammatory cytokines secretion by targetting BRD4 in multiple myeloma
por: Guo, Ning-Hong, et al.
Publicado: (2019)

Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma
por: Tiago, Manoela, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
por: Ye, Yintao, et al.
Publicado: (2023)

BRD4 is a Histone Acetyltransferase that Evicts Nucleosomes from Chromatin
por: Devaiah, Ballachanda N., et al.
Publicado: (2016)

The Bromodomain Protein Brd4 Insulates Chromatin from DNA Damage Signaling
por: Floyd, Scott R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hdcaodo2unm0f6oqc01mlokt8t